Search
for
Sort by
Research 61–90 of 1000+
- Highlights from Recent Cancer Literature
- Fibroblast heterogeneity and functions: insights from single-cell sequencing in wound healing, breast cancer, ovarian cancer and melanoma
- Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm
- Enriching Proteolysis Targeting Chimeras with a Second Modality: When Two Are Better Than One
- Efficacy and tolerability of scalp cooling in preventing alopecia during (neo)adjuvant chemotherapy for breast cancer
- IMPACT OF BIOMARKER IN PREDICATIVE TO RESPONSE ADJUVANT CHEMOTHERAPY AND OVERALL SURVIVAL IN FEMALES INFECTED WITH BREAST CANCER: A REVIEW ARTICLES
- Hormonal contraceptives: pharmacology tailored to women's health
- Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment
- Clinicopathologic Characteristics and Response to Treatment of Persistent Chemotherapy-Induced Alopecia in Breast Cancer Survivors
- B/N-doped carbon nano-onions as nanocarriers for targeted breast cancer therapy
- Efficacy and safety of trastuzumab deruxtecan in the treatment of HER2-low/positive advanced breast cancer: a single-arm meta-analysis
- Stem Cells and their Niches
- 1994 Forthcoming educational events
- Function of KLF4 in Stem Cell Biology
- Steroid Sulfatase: Molecular Biology, Regulation, and Inhibition
- The role of androgens in hormone replacement therapy
- Obesity and the skin
- Safety of testosterone use in women
- Drug safety evaluation of exemestane
- Polycystic Ovary Syndrome: A Comprehensive Review of Its Clinical Presentation, Comorbidities, Long-Term Complications and Management
- Low-Dose Dimethyl Sulfoxide (DMSO) Suppresses Androgen Receptor (AR) and Its Splice Variant AR-V7 in Castration-Resistant Prostate Cancer (CRPC) Cells
- Optimizing hair care products and practices for Black patients with breast cancer: One size does not fit all
- Canadian Expert Recommendations on Safety Overview and Toxicity Management Strategies for Sacituzumab Govitecan Based on Use in Metastatic Triple-Negative Breast Cancer
- Beyond cancer treatment: dermo-aesthetic and other wellness recommendations for breast cancer patients
- The Chinese herb Xiaoaiping protects against breast cancer chemotherapy-induced alopecia and other side effects: a randomized controlled trial
- Anti-invasive effects of minoxidil on human breast cancer cells: combination with ranolazine
- Steroidogenesis in steroid related cancers
- Canagliflozin alleviates progestin resistance by suppressing RARβ/CRABP2 signaling in THRB knockout endometrial cancer cells
- Wedelolactone inhibits breast cancer-induced osteoclastogenesis by decreasing Akt/mTOR signaling
- Selective Androgen Receptor Modulators (SARMs) Negatively Regulate Triple-Negative Breast Cancer Growth and Epithelial:Mesenchymal Stem Cell Signaling